Cancer GeneticsWeb
www.cancer-genetics.org
Navigate
Disclaimer: This site is for educational purposes only; it can not be used in diagnosis or treatment.
  Pancreatic Cancer

Mutated Genes and Abnormal Protein Expression (19)
Overview of the Molecular Biology of Pancreatic Cancer
Familial Clustering of Pancreatic Cancer
Pancreatic Cancer: Clinical and Epidemiological Resources
  Mutated Genes and Abnormal Protein Expression
GeneLocationTopics
ARHC ( RhoC ) 1p21-p13 -RhoC Expression and Prognosis in Ductal Pancreatic Cancer
SLC2A1 ( GLUT1 ) 1p35-p31.3 -GLUT1 Overexpression in Pancreatic Cancer
ID22p25 -ID2 Overexpression in Pancreatic Cancer
TGFBR23p22 -TGFBR2 and Pancreatic Cancer
FGFR18p11.2-p11.1 -FGFR1 Over-Expression in Pancreatic Cancer ?
CDKN2A ( P16 , INK4A , MTS1 ) 9p21 -CDKN2A Mutation in Pancreatic Cancer
TGFBR1 ( ALK5 , ACVRLK4 ) 9q33-q34 -TGFBR1 and Pancreatic Cancer
KAI1 ( CD82 , R2 , ST6 ) 11p11.2 -KAI1 and Pancreatic Cancer
MEN1 ( MENIN ) 11q13 -MEN1 Mutations in Sporadic Pancreatic Cancer
KRAS2 ( Ki-ras , KRAS , K-RAS ) 12p12.1 -KRAS and Pancreatic Cancer
-Organochlorine Compounds and KRAS Mutations
CD9 ( p24 , MIC3 , BA2 ) 12p13 -CD9 and Pancreatic Cancer
BRCA213q12.3 -BRCA2 and Pancreatic Cancer
MAP2K4 ( MKK4 , SEK1 , JNKK1 ) 17p11.2 -MAP2K4 Mutations in Pancreatic Cancer
MADH4 ( DPC4 , SMAD4 ) 18q21.1 -MADH4 and Pancreatic Cancer
DCC ( CRC18 , CRCR1 ) 18q21.3 -DCC and Pancreatic Cancer
STK11 ( LKB1 , PJS ) 19p13.3 -STK11 Mutations in Pancreatic Cancer
AKT219q13.1-q13.2 -AKT2 Amplification in Pancreatic Cancer
BAX19q13.3-q13.4 -BAX and Pancreatic Cancer
TFF1 ( D21S21 , BCEI ) 21q22.3  

 

  Overview of the Molecular Biology of Pancreatic Cancer

Pancreatic cancers are frequently associated with mutation of the KRAS oncogene and inactivating mutations of multiple tumor suppressor genes, particularly TP53, MADH4 (DPC4), CDKN2A (P16), and BRCA2. Also, overexpression of growth factors (EGF, TGF alpha, TGF beta 1-3, aFGF, bTGF) and their associated receptors are also common.

Familial clustering of pancreatic cancer has been reported, germline mutations of BRCA2 and CDKN2A predispose to pancreatic cancer. Mutations in the STk11gene also predisopse to pancreatic cancer in patients with Peutz-Jeghers Syndrome.

  • Coppola D Molecular prognostic markers in pancreatic cancer. Cancer Control 2000 Sep-Oct;7(5):421-7    Related articles (PubMed)

  • Sakorafas GH, et al. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective. Cancer Treat Rev 2000;26(1):29-52    Related articles (PubMed)

  • Tascilar M, et al. Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer [Review] Ann Oncol 1999;10 Suppl 4:107-10    Related articles (PubMed)

  • Goggins M. et al Progress in cancer genetics: lessons from pancreatic cancer. Ann Oncol 1999;10 Suppl 4:4-8 [Review]    Related articles (PubMed)

  • Lamerz R Role of tumour markers, cytogenetics. {{in biliopancreatic malignancies}} Ann Oncol 1999;10 Suppl 4:145-9    Related articles (PubMed)

  • Medline Search: pancreatic cancer AND genetics (PubMed)   Limit search to: [Last Year]  Limit search to: [Last 2 Years]   Limit search to: [Reviews]

    Pancreatic Cancer Genetics
    Pancreatic Cancer : Clinical and Epidemiological Information

     

  •   Familial Clustering of Pancreatic Cancer

  • Banke MG, et al. Inheritance of pancreatic cancer in pancreatic cancer-prone families. Med Clin North Am 2000 May;84(3):677-90    Related articles (PubMed)

  • Hruban RH,et al. Familial pancreatic cancer. Ann Oncol 1999;10 Suppl 4:69-73    Related articles (PubMed)

  • Medline Search: familial pancreatic cancer (PubMed)   Limit search to: [Last Year]  Limit search to: [Last 2 Years]   Limit search to: [Reviews]

    Pancreatic Cancer Genetics
    Pancreatic Cancer : Clinical and Epidemiological Information

     

  •  [Home]       © Copyright 1999-